Poland - Warsaw: Pharmaceutical products

Release

ID: ocds-pyfy63:2019-281845:2019-387488
Buyer: Szpital Bielański im. ks. J. Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej
Date: 2019-08-16
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2019-281845
Releases: 2019-06-18 (ocds-pyfy63:2019-281845:2019-281845)
2019-06-28 (ocds-pyfy63:2019-281845:2019-300343)
2019-08-16 (ocds-pyfy63:2019-281845:2019-387488)

Releases in JSON

Tender

Title: Poland - Warsaw: Pharmaceutical products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure

Accelerated procedure:

Skrócenie terminu składania ofert wynika z zaistnienia stanu pilnej konieczności tj. zapewnienia ciągłości leczenia pacjentów i przeprowadzania zabiegów poprzez ciągłość zaopatrzenia Szpitala w niezbędne produkty lecznicze. Ze względu na charakter przedmiotu zamówienia skrócenie terminu składania ofert nie wpływa w żaden sposób na konkurencyjność postępowania.
Tender period: 2019-08-16 - ?
Tenderers: Farmavol-Logistyka Sp. z o.o.
Sanofi-Aventis Sp. z o.o.
Amgen Sp. z o.o.
Farmacol-Logistyka Sp. z o.o.
Asclepios SA
Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna SA
Abbvie Sp. z o.o.
Ismed Sp. j.
Tekeda Polska Sp. z o.o.

Tender item

ID: ocds-pyfy63:2019-281845:obj:1
Classification: CPV / 33600000
Description: Adalimumab

Tender item

ID: ocds-pyfy63:2019-281845:obj:2
Classification: CPV / 33600000
Description: Alemtuzumab

Tender item

ID: ocds-pyfy63:2019-281845:obj:3
Classification: CPV / 33600000
Description: Darbepoetin alfa

Tender item

ID: ocds-pyfy63:2019-281845:obj:4
Classification: CPV / 33600000
Description: Dimethyl fumarate

Tender item

ID: ocds-pyfy63:2019-281845:obj:5
Classification: CPV / 33600000
Description: Dimethyl fumarate

Tender item

ID: ocds-pyfy63:2019-281845:obj:6
Classification: CPV / 33600000
Description: Fingolimod

Tender item

ID: ocds-pyfy63:2019-281845:obj:7
Classification: CPV / 33600000
Description: Glatiramer acetate

Tender item

ID: ocds-pyfy63:2019-281845:obj:8
Classification: CPV / 33600000
Description: Infliximabum

Tender item

ID: ocds-pyfy63:2019-281845:obj:9
Classification: CPV / 33600000
Description: Interferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:10
Classification: CPV / 33600000
Description: Interferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:11
Classification: CPV / 33600000
Description: Interferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:12
Classification: CPV / 33600000
Description: Interferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:13
Classification: CPV / 33600000
Description: Interferon beta-1b

Tender item

ID: ocds-pyfy63:2019-281845:obj:14
Classification: CPV / 33600000
Description: Palivizumab

Tender item

ID: ocds-pyfy63:2019-281845:obj:15
Classification: CPV / 33600000
Description: Palivizumab

Tender item

ID: ocds-pyfy63:2019-281845:obj:16
Classification: CPV / 33600000
Description: Pasireotidum

Tender item

ID: ocds-pyfy63:2019-281845:obj:17
Classification: CPV / 33600000
Description: Pasireotidum

Tender item

ID: ocds-pyfy63:2019-281845:obj:18
Classification: CPV / 33600000
Description: Pasireotidum

Tender item

ID: ocds-pyfy63:2019-281845:obj:19
Classification: CPV / 33600000
Description: Peginterferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:20
Classification: CPV / 33600000
Description: Peginterferon beta-1a

Tender item

ID: ocds-pyfy63:2019-281845:obj:21
Classification: CPV / 33600000
Description: Teriflunomidum

Tender item

ID: ocds-pyfy63:2019-281845:obj:22
Classification: CPV / 33600000
Description: Vedolizumabum

Tender item

ID: ocds-pyfy63:2019-281845:obj:23
Classification: CPV / 33600000
Description: Natalizumab

Award

ID: ocds-pyfy63:2019-281845:award:0
Title: Adalimumab
Date: 2019-07-30
Status: active
Suppliers: Farmavol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:1
Title: Alemtuzumab
Date: 2019-07-18
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:2
Title: Darbepoetin alfa
Date: 2019-07-18
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:3
Title: Dimethyl fumarate
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:4
Title: Dimethyl fumarate
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:5
Title: Fingolimod
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:6
Title: Glatiramer acetate
Date: 2019-07-30
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2019-281845:award:7
Title: Infliximabum
Date: 2019-07-30
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2019-281845:award:8
Title: Interferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:9
Title: Interferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:10
Title: Interferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna SA

Award

ID: ocds-pyfy63:2019-281845:award:11
Title: Interferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna SA

Award

ID: ocds-pyfy63:2019-281845:award:12
Title: Interferon beta-1b
Date: 2019-07-30
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna SA

Award

ID: ocds-pyfy63:2019-281845:award:13
Title: Palivizumab
Date: 2019-07-18
Status: active
Suppliers: Abbvie Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:14
Title: Palivizumab
Date: 2019-07-18
Status: active
Suppliers: Abbvie Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:15
Title: Pasireotidum
Date: 2019-07-18
Status: active
Suppliers: Ismed Sp. j.

Award

ID: ocds-pyfy63:2019-281845:award:16
Title: Pasireotidum
Date: 2019-07-18
Status: active
Suppliers: Ismed Sp. j.

Award

ID: ocds-pyfy63:2019-281845:award:17
Title: Pasireotidum
Date: 2019-07-18
Status: active
Suppliers: Ismed Sp. j.

Award

ID: ocds-pyfy63:2019-281845:award:18
Title: Peginterferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:19
Title: Peginterferon beta-1a
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:20
Title: Teriflunomidum
Date: 2019-07-18
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:21
Title: Vedolizumabum
Date: 2019-07-18
Status: active
Suppliers: Tekeda Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2019-281845:award:22
Title: Natalizumab
Date: 2019-07-30
Status: active
Suppliers: Farmacol-Logistyka Sp. z o.o.

Parties

Roles: buyer
Organization name: Szpital Bielański im. ks. J. Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej
Street address: ul. Cegłowska 80
Locality: Warszawa
Postal code: 01-809
Country: PL
Contact name: Janusz Kurek
E-mail: zp@bielanski.med.pl
Phone: +48 225690159
Fax: +48 225690247
Website: www.bielanski.bip-e.pl